期刊文献+

HPVL1壳蛋白在宫颈脱落细胞及宫颈组织中的表达及意义 被引量:3

Expressions and significances of HPV L1 capsid protein in cervical exfoliated cells and cervical tissue
原文传递
导出
摘要 目的:探讨HPVL1壳蛋白在宫颈脱落细胞及宫颈组织中的表达及临床意义。方法:随机选取来医院就诊患者的宫颈脱落细胞标本782例用免疫细胞化学法检测HPVL1壳蛋白的表达,用免疫组织化学方法检测224例宫颈病变组织中HPVL1壳蛋白的表达。结果:HPVL1壳蛋白在NLIM、ASCUS、ASCU-H、LSIM、HSIM中的阳性表达率分别为49.24%(130/264)、43.90%(72/164)、20.54%(23/122)、18.18%(24/132)、15.45%(17/110)。HPVL1壳蛋白在慢性宫颈炎、CINⅠ、CINⅡ、CINⅢ中的阳性表达率分别为42.86%(24/56)、36.11%(26/72)、15.63%(10/64)、6.25%(2/32)。各组织学分级患者HPVL1衣壳蛋白的阳性率差异有统计学意义(P=0.00)。结论:HPVL1壳蛋白在宫颈脱落细胞及宫颈病变组织中的表达率随病变程度的加重均呈下降趋势。 Objective: To explore the expressions and significances of HPV L1 capsid protein in cervical exfoliated cells and cervi- cal tissue. Methods: The expression of HPV L1 capsid protein in cervical exfoliated cells of 782 patients randomly selected from the hospital was detected by immunocytochemical method, and the expression of HPV L1 capsid protein in cervical lesion specimens of 224 patients was detected by immunocytoehemical method. Results: The positive expression rates of HPV L1 capsid protein in NLIM, ASCUS, ASCU - H, LSIM and HSIM were 49.24% (130/264), 43.90% (72/164), 20.54% (23/122), 18. 18% (24/132) and 15.45% (17/110), re- spectively. The positive expression rates of HPV L1 capsid protein in chronic cervicitis, CIN Ⅰ , CIN Ⅱ and CIN Ⅲ were 42. 86% (24/56), 36. 11% (26/72), 15.63% (10/64) and 6. 25% (2/32), respectively. There was statistically significantly difference in positive expres- sion rate of HPV L1 eapsid protein among patients of different histological grades (P = 0. 00) . Conclusion: The expression rates of HPV L1 eapsid protein in cervical exfoliated cells and cervical tissue show decreasing trend with aggravation of the disease.
出处 《中国妇幼保健》 CAS 北大核心 2014年第14期2245-2247,共3页 Maternal and Child Health Care of China
基金 河南省教育厅科学技术研究重点项目〔13A310448〕
关键词 宫颈上皮内瘤变 人乳头瘤病毒 L1壳蛋白 Cervical intraepithelial neoplasia Humanpapillomavirus L1 capsid protein
  • 相关文献

参考文献7

二级参考文献30

  • 1Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA, 1999, 281 : 1605- 1610. 被引量:1
  • 2Siddiqui MT, Hornaman K, Cohen C, et al. ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASCUS) cytology: correlation study with histologic biopsy. Arch Pathol Lab Med, 2008, 132 : 1648-1652. 被引量:1
  • 3Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev, 2003, 16:1-17. 被引量:1
  • 4Doorbar J. The papillomavirus life cycle. J Clin Virol, 2005, 32 Suppl 1 :S7-15. 被引量:1
  • 5Yoshida T, Sano T, Kanuma T, et al. Immunochemical analysis of HPV LI capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions. Cancer, 2008, 114:83-88. 被引量:1
  • 6Evander M, Edlund K, Gustafsson A, et al. Human papillomavirus infection is transient in young women : a population-based cohort study. J Infect Dis, 1995, 171:1026-1030. 被引量:1
  • 7Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst, 2000, 9:464-474. 被引量:1
  • 8Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 1998, 338:423-428. 被引量:1
  • 9Stanley M. Immune responses to human papillomavirus. Vaccine, 2006, 24 Suppl 1 :S16-22. 被引量:1
  • 10Stanley M, Lowy DR, Frazer I. Chapter 12: Prophylactic HPV vaccines : underlying mechanisms. Vaccine, 2006, 24 : 106-113. 被引量:1

共引文献50

同被引文献24

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部